Dolby Laboratories, Inc.
DLB
$75.75
-$0.04-0.05%
NYSE
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Net Income | 262.67M | 261.83M | 212.44M | 190.40M | 188.26M |
| Total Depreciation and Amortization | 91.56M | 87.33M | 87.20M | 90.30M | 94.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.03M | 84.70M | 109.47M | 126.88M | 116.62M |
| Change in Net Operating Assets | -17.64M | -106.60M | -113.01M | -11.61M | -79.90M |
| Cash from Operations | 425.62M | 327.25M | 296.10M | 395.96M | 319.10M |
| Capital Expenditure | -30.69M | -30.01M | -30.81M | -30.61M | -29.22M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -489.24M | -487.88M | 0.00 | 25.70M | 25.70M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 224.86M | 231.59M | -13.88M | -10.01M | 30.06M |
| Cash from Investing | -295.07M | -286.29M | -44.70M | -14.92M | 26.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 44.06M | 40.93M | 50.76M | 56.45M | 55.85M |
| Repurchase of Common Stock | -131.95M | -199.08M | -204.95M | -195.40M | -220.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -117.58M | -114.58M | -111.79M | -108.93M | -106.09M |
| Other Financing Activities | -14.78M | -15.08M | -4.51M | -1.05M | -1.05M |
| Cash from Financing | -220.25M | -287.81M | -270.49M | -248.92M | -271.86M |
| Foreign Exchange rate Adjustments | -7.31M | 6.64M | -1.44M | -1.18M | 3.41M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -97.00M | -240.21M | -20.54M | 130.94M | 77.18M |